新的NCI精准医学试验
Lyndsay N Harris1, Charles D Blanke2, Harry P Erba3
1Division of Cancer Treatment and Diagnosis, NCI, Bethesda, Maryland.
概括
像NCI-MATCH这样的主协议先进的精确瘤学. 较新的NCI试验 (ComboMATCH,iMatch,myeloMATCH) 探索有针对性的治疗组合,以改善癌症转移性疾病控制.
科学领域:
- 在瘤学瘤学.
- 精准医学是一门精准的医学.
- 临床试验设计 临床试验设计
背景情况:
- 在过去的十年里,包括篮子,雨和平台试验在内的主协议在瘤学中获得了研究精准医学的突出地位.
- 第一代试验,如NCI-MATCH (治疗选择的分子分析),从实验室和临床的角度证明了大规模向治疗研究的可行性.
- 单剂向疗法在控制转移性癌症方面表现出有限的有效性,即使具有精确的药物向匹配.
研究的目的:
- 介绍和讨论NCI发起的三项第二代精密医学试验的设计和必要基础设施.
- 通过探索新的方法来解决单剂向疗法的局限性,包括向疗法或向疗法与标准治疗的组合.
- 通过开发组合治疗的创新临床试验设计,推进精密瘤学领域的发展.
主要方法:
- 讨论了NCI领导的新精准医学试验背后的设计原则:ComboMATCH,iMatch和myeloMATCH.
- 探索实施这些复杂,多臂,多阶段试验设计的基础设施需求.
- 专注于在总体协议框架内转向组合疗法的战略转变.
主要成果:
- 摘要没有提出具体的结果,但讨论了新的试验的逻辑和设计.
- 强调从第一代单剂向治疗试验到第二代组合治疗试验的过渡.
- 强调了先进的主协议设计的可行性和必要性,用于未来的精确瘤学研究.
结论:
- 第二代精准医学试验对于克服转移性癌症单剂疗法的局限性至关重要.
- 国家医学研究中心的新试验 (ComboMATCH,iMATCH,myeloMATCH) 代表了组合疗法主协议设计的重大进展.
- 有效的基础设施和创新的试验设计对于大规模精确瘤学研究的成功实施至关重要.
相关概念视频
Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K


